|
Spectrum of activity:
|
Gram-positive
&
Gram-negative
|
|
Details of activity:
|
Active against Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Salmonella typhimurium
|
|
Description:
|
Natural product from a mutant Micromonospora inyoensis; requires the addition of 2-deoxystreptamine analogues or streptamine in media for compound to be produced
|
|
Institute where first reported:
|
Microbiological and Medicinal Chemistry Divisions, Schering Corporation, Bloomfield, N. J., 07003 U.S.A.
|
|
Year first mentioned:
|
1974
|
|
Development status:
|
Experimental
|